Delivery Order SPE2DB22D2206-SPE2DB25FFX43

Award Date 3/3/25
Potential Completion Date 3/24/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,952.92 firm fixed-price delivery order contract is for the supply of IMFINZI 500 mg/10 ml vials, a specialty oncology medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $15,420.00, is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the delivery of a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award from the Defense Logistics Agency (DLA) is a $25,700 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 500 mg/10 mL vials of the prescription drug IMFINZI. The contract is set to run through April 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly supporting the medical needs of military personnel and veterans. This delivery order is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,233.28 firm fixed-price delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, with a completion date of July 14, 2023. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,525.70, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. This award is associated with a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a specialty medication, with a ceiling value of $7,976.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,294.10 firm fixed-price delivery order is for 4566554698 - IMFINZI 500 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of December 18, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $15,420.00 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4564933251 IMFINZI 500 MG/10 ML VIAL 10ML, with a period of performance through July 10, 2024. This Delivery Order contract is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $23,130.00 fixed-price delivery order is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a $999,999,999.00 Indefinite Delivery Contract with the DLA through December 2025. This single-award...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFX43
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,525.70 Firm Fixed Price Delivery Order contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award, while not designated with a set-aside, is part of the company's broader distribution of essential medical commodities to federal agencies, including the Defense Department and other government healthcare programs.

Generated 6/2/25, 9:57 AM